Holen Sie sich die Stockscreener-App
60.12
0.10%
-0.04
Schlusskurs vom Vortag:
$60.16
Offen:
$60.35
24-Stunden-Volumen:
2.37M
Relative Volume:
0.50
Marktkapitalisierung:
$29.59B
Einnahmen:
$163.07B
Nettoeinkommen (Verlust:
$3.31B
KGV:
9.6346
EPS:
6.24
Netto-Cashflow:
$-490.00M
1W Leistung:
+1.06%
1M Leistung:
-2.95%
6M Leistung:
-7.25%
1J Leistung:
-19.66%
1-Tages-Spanne:
$59.81
$60.83
1-Wochen-Bereich:
$58.49
$60.83
52-Wochen-Spanne:
$55.03
$80.59
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Vergleichen Sie CNC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
60.15 | 29.59B | 163.07B | 3.31B | -490.00M | 6.24 |
|
UNH
Unitedhealth Group Inc
|
408.68 | 382.29B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
416.67 | 93.50B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.27 | 90.77B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.53 | 81.97B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
259.39 | 31.77B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
CENTENE SUBSIDIARY ARIZONA COMPLETE HEALTH JOINS SETTLEMENT AGREEMENT TO MOVE FORWARD WITH STATEWIDE LONG-TERM CARE MEDICAID CONTRACT - PR Newswire
Health Insurance Market Size to Lead USD 5,190 Bn by 2034 Rising chronic diseases and healthcare costs are fueling demand for coverage - GlobeNewswire Inc.
Oklahoma Complete Health Offers New and Upgraded Benefits for SoonerSelect Members in 2025 - Financial Times
New Strong Buy Stocks for May 1st - TradingView
Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander - Yahoo Finance
Centene Corporation (CNC): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential - Insider Monkey
Centene stock price target cut to $61 by Jefferies - Investing.com South Africa
Jefferies Adjusts Price Target for Centene (CNC), Maintains Hold Rating | CNC Stock News - GuruFocus
Centene Corp. stock outperforms competitors on strong trading day - MSN
Centene (CNC) Sees Price Target Reduction by Barclays to $84 | C - GuruFocus
Centene Corporation (CNC): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential - Insider Monkey
Forecasting The Future: 4 Analyst Projections For Centene - Benzinga
Centene (CNC) Price Target Reduced Amid Mixed Outlook | CNC Stoc - GuruFocus
Decoding Centene Corp (CNC): A Strategic SWOT Insight - GuruFocus
Centene Corp. stock underperforms Friday when compared to competitors - MSN
Centene Corporation (NYSE:CNC) Q1 2025 Earnings Call Transcript - Insider Monkey
Centene: Q1 Earnings Snapshot - CT Insider
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... - Yahoo Finance
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Wins ... By GuruFocus - Investing.com Canada
Centene Corp (CNC) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Centene, Molina Post Solid 1Q Earnings, but Investors Remain Skeptical - AIS Health
Centene (CNC) Shares Drop Amid Mixed Q1 2025 Results - GuruFocus
Why Centene (CNC) Shares Are Trading Lower Today - The Globe and Mail
Centene Q1 Earnings Beat Estimates On Marketplace Business Strength - Barchart.com
Centene stock falls on fear of Medicaid cuts, CEO sounds optimistic note - The Business Journals
Centene (CNC) Outperforms with Strong Q1 Revenue, Reaffirms 2025 Outlook | CNC Stock News - GuruFocus
Centene Q1 Earnings Beat Estimates on Marketplace Business Strength - Yahoo Finance
Unpacking claim DeSantis funneled Florida taxpayer money through his wife's charity - Snopes
Earnings call transcript: Centene beats Q1 2025 EPS forecast, stock drops - Investing.com
Centene (CNC) Adjusts Health Expenses Outlook Amid Strong Revenue Growth - GuruFocus
Centene Raises Revenue Guidance on Higher Health Plan Sales (CNC) - Bloomberg.com
Centene Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Insurer Centene Reaffirms Annual Profit Guidance, Reports Better Than Expected Q1 EarningsCentene (NYSE:CNC) - Benzinga
Part of the former Centene campus in University City will now be apartments - Charlotte Observer
Centene (CNC) Surpasses Q1 Earnings Expectations with Strong Gro - GuruFocus
Centene Corp (CNC) Q1 2025 Earnings: EPS of $2.90 Beats Estimate - GuruFocus
Centene’s (NYSE:CNC) Q1 Sales Beat Estimates, Guides For Strong Full-Year Sales - Barchart.com
Centene Corporation Reports First Quarter 2025 Results - TradingView
Centene Corporation Q1 Profit Increases, Beats Estimates - Nasdaq
CENTENE CORP SEC 10-Q Report - TradingView
CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS - Yahoo Finance
Developer wins rezoning approval for Centene-owned land - Yahoo
Health Net, Dignity Health and Vivant Health Partner to Improve Patient Care in Sacramento Hospitals - Quantisnow
Centene's Earnings: A Preview - Benzinga
Ex-Exec Says Centene Harassed Him Over Void Noncompete - Law360
Can Centene Beat Q1 Earnings Estimates on Growing Premiums? - TradingView
Florida Medicaid regulator offers explanation of scrutinized $10M Hope Florida donation - Politico
Health system names former Centene exec president of 2 local hospitals - The Business Journals
Atlanta developer wins rezoning nod for sprawling project on Centene-owned land - The Business Journals
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):